BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Dimethyl Fumarate

A fumarate derivative that is used as a DERMATOLOGIC AGENT in the treatment of PSORIASIS and SKIN DISEASES. It also may be used as an IMMUNOSUPPRESSIVE AGENT in the treatment of MULTIPLE SCLEROSIS.

296+ PubMed studies analyzed · 7 RCTs · Evidence Score: 45.8

Research Domains

Dimethyl Fumarate has been studied across 20 research domains including 🛡️ Immunity, 🔬 Inflammation, 😴 Sleep, 🔬 Oncology, 🧘 Stress & Anxiety. The primary research focus is 🛡️ Immunity with 41% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Dimethyl Fumarate, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

alyssin
3 shared targets
Dutasteride
2 shared targets
Niacin
2 shared targets
Phenytoin
2 shared targets
Betamethasone
2 shared targets
Melatonin
2 shared targets
Hydrocortisone
2 shared targets
Cytarabine
2 shared targets
2-Methoxyestradiol
2 shared targets
Febuxostat
2 shared targets
Loading evidence profile...

This evidence profile for Dimethyl Fumarate is generated deterministically from 296 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.